Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.

about

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter

P2860

Q59133388-D1239C3B-2E50-4AE2-A196-C7C6868B6631

P2860

Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.

Item

http://www.wikidata.org/entity/Q55287855

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Genetic Landscape of Acute Mye ...... arge Cancer Center Experience.

@en

Genetic Landscape of Acute Mye ...... arge Cancer Center Experience.

@nl

type

Item

label

Genetic Landscape of Acute Mye ...... arge Cancer Center Experience.

@en

Genetic Landscape of Acute Mye ...... arge Cancer Center Experience.

@nl

prefLabel

Genetic Landscape of Acute Mye ...... arge Cancer Center Experience.

@en

Genetic Landscape of Acute Mye ...... arge Cancer Center Experience.

@nl

P1476

Genetic Landscape of Acute Mye ...... Large Cancer Center Experience

@en

P2093

Eric Padron

http://www.w3.org/2001/XMLSchema#string

Jeffrey Lancet

http://www.w3.org/2001/XMLSchema#string

Jinming Song

http://www.w3.org/2001/XMLSchema#string

Mohammad Omar Hussaini

http://www.w3.org/2001/XMLSchema#string

Rami Komrokji

http://www.w3.org/2001/XMLSchema#string

P2860

ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.

Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.

P304

121-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/CGP.20070

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Abu-Sayeef Mirza

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29496691

http://www.w3.org/2001/XMLSchema#string

P932

5892606

http://www.w3.org/2001/XMLSchema#string

Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.

about

P2860

P2860

Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932